Unlocking Market Success for Pharma & MedTech in Africa
We specialize in accelerating pharmaceutical and MedTech market access across Africa, ensuring compliance, HCP engagement, and sustainable growth.
Regulatory & Compliance Support
- Expert regulatory support across African markets for faster market entry.
- Streamlined licensing and product registration to reduce time-to-market.
- Compliant with GDPR and local data protection laws for secure HCP engagement.
Healthcare Provider (HCP) Engagement & Training
- CME-accredited HCP training via multilingual digital platforms.
- Hybrid learning model—combining in-person and virtual engagements.
- Real-time analytics to track HCP participation and knowledge retention
Market Access & Expansion Strategies
- Data-driven market access solutions for pharma and medtech.
- MoH-aligned strategies for regulatory and commercial integration.
- Customized go-to-market plans for sustainable growth in Africa.
Localization & Multilingual Support
- Bilingual (English/French) platforms for inclusive HCP learning.
- Localized digital campaigns to reach regional and multilingual audiences.
- Boost HCP adoption with culturally tailored content and outreach.
Proven Impact
Real success stories from our partnerships with leading healthcare organizations
115,000+
Total HCPs trained
250,000+
Total HCPs reached
102+
Countries reached
750+
Number of activities
Success Story I
Challenge
Low awareness and limited knowledge among healthcare professionals (HCPs) have hindered the effective use of Kenya’s pharmacovigilance system for adverse event reporting. Many HCPs struggle to access and navigate the system, leading to underreporting of drug safety concerns. Additionally, the system’s value has not been fully demonstrated, resulting in low engagement.
Solution
Supported by a grant from Pfizer, we conducted 12 online CME sessions for a duration of one year to educate HCPs on pharmacovigilance. These sessions provided practical training on adverse event reporting and system navigation, engaging experts and institutions for wider impact.
Impact
- 16,355 registrations and 12,127 attendees (73% attendance rate).
- 5,298 unique learners.
- High engagement across various HCP cadres, particularly pharmacists and pharmaceutical technologists.
Impact
The solution notably improved detection rates to 96.57% accuracy, decreasing the overuse of antibiotics, helping combat AMR.
Success Story II
Challenge
Antimicrobial resistance (AMR) is a critical public health issue globally. In Kenya, over 50% of antibiotics in community pharmacies are used without prescriptions. In 2019, the widespread misuse of antibiotics fueled resistance, contributing to 8,500 deaths directly and 37,300 deaths overall in Kenya. Limited access to formal healthcare has led many people to rely on self-medication, increasing the risk of drug-resistant infections.
Solution
To combat AMR, we are introducing a mobile AI-powered diagnostic tool that transforms healthcare workers' smartphones into real-time infection screening devices. This innovative solution allows for rapid, on-the-spot diagnosis without the need for laboratory infrastructure. The technology has already undergone multiple trials, including in Uganda, and is now being prepared for clinical trials in Kenya, India, the U.S., and other countries.